Xilio Therapeutics annual revenue
2024
2025
Xilio Therapeutics Revenue Growth & History (XLO)
Xilio Therapeutics reported $43.8M in revenue for fiscal 2025, an increase of 589.88% from the previous fiscal year.
View full Xilio Therapeutics company overviewXilio Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $43.8M | $37.4M | +589.88% |
| 2024 | 2024-12-31 | $6.3M | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Xilio Therapeutics filings at SEC.gov ↗